Detalhe da pesquisa
1.
Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy.
Oncotarget
; 11(45): 4195-4200, 2020 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33227091
2.
Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial.
Oncotarget
; 10(54): 5605-5621, 2019 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31608137
3.
Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy.
Oncotarget
; 13: 1215, 2022 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342460